Intravitreal triamcinolone for the treatment of macular oedema

Eye

Volumn 20, Issue 1, 2006, Pages 1-2

  Pathmanathan, T ^a   Reck, Anne C ^a  

^a DORSET COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADJUVANT THERAPY; ANTIINFLAMMATORY ACTIVITY; CATARACT; CATARACT EXTRACTION; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONJUNCTIVA DISEASE; DIABETES MELLITUS; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; ENDOPHTHALMITIS; EYE TOXICITY; GLAUCOMA; HUMAN; LASER COAGULATION; NONHUMAN; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; RETINA DISEASE; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; VISUAL ACUITY;

EID: 30744461644     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701802     Document Type: Editorial

References (10)

1. McCuen II BW, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981; 91(6): 785-788.
2. Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W et al. Safety of an intravitreal injection of triamcinolone: Results from a randomized clinical trial. Arch Ophthalmol 2004; 122(3): 336-340.
3. Negi AK, Vernon SA, Lim CS, Owen-Armstrong K. Intravitral triamcinolone improves vision in eyes with chronic diabetic macular ooedema refractory to laser photocoagulation. Eye 2004; September 10, [E-pub ahead of print].
4. Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S. Intravitreal triamcinolone for the treatment of refractory diabetic macular ooedema with hard exudates: An optical coherence tomography study. Br J Ophthalmol 2004; 88(9): 1131-1136.
5. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular oedema. Arch Ophthalmol 2003; 121(1): 57-61.
6. Bashshur ZF, Ma'luf RN, Allam S, Jurdi FA, Haddad RS. Noureddin intravitreal triamcinolone for the management of macular oedema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 2004; 122(8): 1137-1140.
7. Rechtman E, Danis RP, Pratt LM, Harris A. Intra vitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2004; 88(3): 344-347.
8. Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular oedema. Am J Ophthalmol 2003; 135(2): 246-249.
9. Jonas JB, Kreissig I, Degenring RF. Treatment of oedematous, proliferative and neovascular diseases with intravitreal triamcinolone. Klin Monatssbl Augenheilkd 2003; 220(6): 383.
10. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87(1): 24-27.